Collaboration solves
Carlson et al., 21 (Rob Carlson Chad Sbragia, and Kate Sixt, 9-14-2021, "Beyond Biological Defense: Maintaining the U.S. Biotechnology Advantage," War on the Rocks, https://warontherocks.com/2021/09/beyond-biological-defense-maintaining-the-u-s-biotechnology-advantage/, LASA-CSK)
The Pentagon needs to expand its approach to biotechnology beyond biodefense. If China maintains biological warfare aspirations, by all means address those. But defense planners should also address China’s broader approach to biotechnology and its integrated approach to civil-military fusion.
Securing biotechnology secures the nation. Maintaining the U.S. lead in biotechnology is critical to the nation’s economic and military resilience in war, peace, and the gray zone short of conflict. This requires better biotechnology collaboration — within the U.S. government, with allies and partners, and even, where possible, with competitors.